| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-12 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |